MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Whole-Exome Sequencing in a Movement Disorders Clinic

    C. Shah, L. Robak, E. Hill, J. Jankovic (Houston, USA)

    Objective: To evaluate the diagnostic utility of whole-exome sequencing (WES) in select patients with a movement disorder. Background: Many patients with suspected genetic movement disorders…
  • MDS Virtual Congress 2021

    Using Human Neural Tissue Methylation to Decipher Epigenetic Characteristics and Cell Type Pathologies in Huntington’s Disease

    A. Glaser, J. Levy, Z. Zhang, L. Salas (Hanover, USA)

    Objective: This study combines methylation data from the two largest EWAS studies in Huntington's Disease (HD) human brain tissue [1,2]. Combined, this study yields the…
  • MDS Virtual Congress 2021

    Characterizing US Healthcare Delivery in Huntington’s Disease (HD)

    L. Seeberger, J. Corey-Bloom, M. O'Brien, P. Chen, B. Griffin, D. Schlang, D. Slowiejko (Aurora, USA)

    Objective: The HD-Net research survey aimed to assess care patterns among practice types in the U.S., to identify gaps in the provision of HD care.…
  • MDS Virtual Congress 2021

    SARS-CoV-2 Encephalopathy Presenting as Opsoclonus Myoclonus Syndrome Successfully Treated with IV Immunoglobulins

    M. Salgado, I. Hacker, A. Alport, J. Ma (Brooklyn, USA)

    Objective: To present a case of a SARS-CoV-2 patient presenting with opsoclonus myoclonus syndrome who was successfully treated with IVIGs. Background: The COVID-19 pandemic has…
  • MDS Virtual Congress 2021

    Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism

    L. Andreoli, M. Abbaszadeh, X. Cao, A. Cenci Nilsson (Lund, Sweden)

    Objective: We set out to compare patterns of dyskinetic behaviours induced by the systemic administration of L-DOPA and D1 or D2 receptor (D1R, D2R) agonists…
  • MDS Virtual Congress 2021

    Can event-related oscillations aid in differentiating Parkinson’s disease and dementia with Lewy bodies?

    Y. Rosenblum, T. Shiner, N. Bregman, I. Maidan, F. Fahoum, N. Giladi, A. Mirelman (Tel Aviv, Israel)

    Objective: To assess the specificity of an EEG signature of the visual event-related oscillations (ERO) in synucleinopathies. Background: Parkinson's disease (PD), PD dementia (PDD) and…
  • MDS Virtual Congress 2021

    Neuroleptic Malignant Syndrome: Case Series of Movement Disorders Emergency

    IAH. Hakim, NR. Raisa, WMS. Santoso, CAS. Setianto (Malang, Indonesia)

    Objective: We describe four cases of Neuroleptic Malignant Syndrome (NMS) with high mortality rates, despite decreased reports of the disease in the past decades. Background:…
  • MDS Virtual Congress 2021

    EFFECT OF TRANSCRANIAL DIRECT CURRENT STIMULATION (tDCS) ON LOCOMOTOR FUNCTION IN PATIENTS WITH PARKINSON’S DISEASE

    M. Shah, B. Bajaj, I. Ali (New Delhi, India)

    Objective: Objectives Primary objective: To determine the effect of bilateral anodal transcranial direct current stimulation (tDCS) on locomotor function in patients with Parkinson’s disease immediately…
  • MDS Virtual Congress 2021

    Disparities in Access to Spasticity Chemodenervation Specialists in the United States: a National Analysis of Medicare Data

    R. Kazerooni, S. Healy, M. Verduzco-Gutierrez (Raleigh, USA)

    Objective: To explore the variations in access to spasticity chemodenervation specialists across several geographical, ethnic, racial, and population density factors. Background: Equity in access to…
  • MDS Virtual Congress 2021

    Modeling of the Placebo Response in Parkinson’s Disease

    S. Branders, O. Rascol, G. Garraux, B. Berman, G. Stebbins, C. Goetz, C. Billocq, A. Pereira (Mont-Saint-Guibert, Belgium)

    Objective: The objective of this study was to investigate the predictability of the placebo response in Parkinson's disease (PD) subjects participating in a randomized clinical…
  • « Previous Page
  • 1
  • …
  • 66
  • 67
  • 68
  • 69
  • 70
  • …
  • 132
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley